| Q57167723 | 3D culture models for studying branching morphogenesis in the mammary gland and mammalian lung |
| Q36987541 | A Method for Sectioning and Immunohistochemical Analysis of Stem Cell-Derived 3-D Organoids |
| Q42361478 | A SILAC-Based Method for Quantitative Proteomic Analysis of Intestinal Organoids |
| Q37385288 | A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids |
| Q38649378 | A pathologist's perspective on induced pluripotent stem cells |
| Q40230465 | A three-dimensional model of human lung development and disease from pluripotent stem cells. |
| Q92739425 | Airway regeneration using iPS cell-derived airway epithelial cells with Cl- channel function |
| Q64282521 | Alveolus-like organoid from isolated tip epithelium of embryonic mouse lung |
| Q98611638 | Animal and translational models of SARS-CoV-2 infection and COVID-19 |
| Q27324252 | Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures |
| Q29248141 | Barriers to inhaled gene therapy of obstructive lung diseases: A review |
| Q93137039 | Biologically inspired approaches to enhance human organoid complexity |
| Q30358385 | Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing |
| Q93067800 | Building and Regenerating the Lung Cell by Cell |
| Q51739244 | CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers. |
| Q39105613 | CRISPR/Cas 9 genome editing and its applications in organoids |
| Q64940785 | CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells. |
| Q49967066 | Can We Understand the Pathobiology of Bronchopulmonary Dysplasia? |
| Q42777063 | Cellular heterogeneity in the ureteric progenitor niche and distinct profiles of branching morphogenesis in organ development. |
| Q64245218 | Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis |
| Q50090313 | Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine. |
| Q39125379 | Clinical potentials of human pluripotent stem cells. |
| Q48258260 | Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. |
| Q94595011 | Comparison of two human organoid models of lung and intestinal inflammation reveals Toll-like receptor signalling activation and monocyte recruitment |
| Q97528820 | Composite Hydrogels in Three-Dimensional in vitro Models |
| Q88707179 | Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models |
| Q39009739 | Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells |
| Q92134949 | De novo lung biofabrication: clinical need, construction methods, and design strategy |
| Q96220924 | Delineating the early transcriptional specification of the mammalian trachea and esophagus |
| Q91303038 | Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells |
| Q50074335 | Design of biomimetic substrates for long-term maintenance of alveolar epithelial cells |
| Q57833367 | Development and Bioengineering of Lung Regeneration |
| Q33722565 | Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling |
| Q47719385 | Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells. |
| Q38807015 | Directed Induction of Functional Multi-ciliated Cells in Proximal Airway Epithelial Spheroids from Human Pluripotent Stem Cells. |
| Q47100977 | Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells |
| Q52430924 | Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells. |
| Q66678801 | Disease modelling in human organoids |
| Q64923977 | Effects of lung and airway epithelial maturation cocktail on the structure of lung bud organoids. |
| Q52884838 | Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. |
| Q38685792 | Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro. |
| Q89529496 | Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies |
| Q57025463 | Esophageal Organoids from Human Pluripotent Stem Cells Delineate Sox2 Functions during Esophageal Specification |
| Q39234248 | Establishing Proximal and Distal Regional Identities in Murine and Human Tissue-Engineered Lung and Trachea |
| Q40089850 | Experimental study of tuberculosis: From animal models to complex cell systems and organoids. |
| Q97526558 | Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease |
| Q48183595 | FGF2-dependent mesenchyme and laminin-111 are niche factors in salivary gland organoids |
| Q58614050 | From single cells to tissue self-organization |
| Q89574032 | Functional Evidence of Pulmonary Extracellular Vesicles in Infectious and Noninfectious Lung Inflammation |
| Q64058281 | Functional ectodermal organ regeneration as the next generation of organ replacement therapy |
| Q37673612 | Gastrointestinal Organoids: Understanding the Molecular Basis of the Host-Microbe Interface. |
| Q89900769 | Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches |
| Q58609920 | Generating Embryonic Salivary Gland Organoids |
| Q97517756 | Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation |
| Q91012494 | Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells |
| Q64277444 | Generation of lung organoids from human pluripotent stem cells in vitro |
| Q36506651 | Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids |
| Q33628093 | Genome engineering of stem cell organoids for disease modeling |
| Q90711201 | Glycogen synthase kinase 3 induces multilineage maturation of human pluripotent stem cell-derived lung progenitors in 3D culture |
| Q26747226 | How to Grow a Lung: Applying Principles of Developmental Biology to Generate Lung Lineages from Human Pluripotent Stem Cells |
| Q36183446 | Human airway organoid engineering as a step toward lung regeneration and disease modeling. |
| Q50074648 | Human iPSC-Derived Posterior Gut Progenitors Are Expandable and Capable of Forming Gut and Liver Organoids |
| Q90261702 | Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure |
| Q58776208 | Human lung development: recent progress and new challenges |
| Q47830268 | Human lung epithelial cell cultures for analysis of inhaled toxicants: Lessons learned and future directions. |
| Q97418936 | Human organoids: model systems for human biology and medicine |
| Q47094121 | Humans in a Dish: The Potential of Organoids in Modeling Immunity and Infectious Diseases |
| Q101051356 | Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids |
| Q41012880 | In Vitro Experimental Model for the Long-Term Analysis of Cellular Dynamics During Bronchial Tree Development from Lung Epithelial Cells. |
| Q38707919 | In Vitro Models to Study Human Lung Development, Disease and Homeostasis. |
| Q90696036 | In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells |
| Q37711218 | In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development. |
| Q39040578 | Induced pluripotent stem cell technology: a decade of progress |
| Q90672879 | Investigating pediatric disorders with induced pluripotent stem cells |
| Q47241949 | In Vitro Induction and In Vivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells |
| Q89936505 | In Vitro and In Vivo Development of the Human Airway at Single-Cell Resolution |
| Q38558317 | Kidney Organoids: A Translational Journey |
| Q92184212 | Kidney organoids in translational medicine: Disease modeling and regenerative medicine |
| Q37297775 | LGR4 and LGR5 Function Redundantly During Human Endoderm Differentiation. |
| Q64244995 | Long-term expanding human airway organoids for disease modeling |
| Q87970894 | Long-term self-renewing human epicardial cells generated from pluripotent stem cells under defined xeno-free conditions |
| Q39029148 | Looking ahead: where to next for animal models of bronchopulmonary dysplasia? |
| Q38673050 | Lung Organoids and Their Use To Study Cell-Cell Interaction |
| Q38745858 | Lung organoids: current uses and future promise. |
| Q39306963 | Modeling Cancer with Pluripotent Stem Cells |
| Q24657457 | Modeling Development and Disease with Organoids |
| Q59133328 | Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age |
| Q36136522 | Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids |
| Q64937660 | Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. |
| Q47747683 | Modeling rare diseases with induced pluripotent stem cell technology. |
| Q52726726 | Morphological alterations of cultured human colorectal matched tumour and healthy organoids. |
| Q90110358 | Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery |
| Q57826256 | Naturally-Derived Biomaterials for Tissue Engineering Applications |
| Q52430564 | New tools for old drugs: Functional genetic screens to optimize current chemotherapy. |
| Q92542959 | Next-Generation Liver Medicine Using Organoid Models |
| Q64240311 | Nonadhesive Alginate Hydrogels Support Growth of Pluripotent Stem Cell-Derived Intestinal Organoids |
| Q47562383 | Opportunities for organoids as new models of aging |
| Q26771646 | Organoid Models of Human Gastrointestinal Development and Disease |
| Q38157238 | Organoid culture systems to study host-pathogen interactions |
| Q38716335 | Organoid technologies meet genome engineering |
| Q59792231 | Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine |
| Q28271001 | Organoids and the genetically encoded self-assembly of embryonic stem cells |
| Q91637548 | Organoids as a Powerful Model for Respiratory Diseases |
| Q38748913 | Organoids as an in vitro model of human development and disease. |
| Q60015369 | PEG-4MAL hydrogels for human organoid generation, culture, and in vivo delivery |
| Q38786566 | Patient-derived induced pluripotent stem cells in cancer research and precision oncology. |
| Q93133432 | Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening |
| Q91869804 | Perspective: The promise of multi-cellular engineered living systems |
| Q39393830 | Phenotypic Analysis of Organoids by Proteomics |
| Q90084237 | Pluripotent Stem Cell Platforms for Drug Discovery |
| Q47744477 | Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung- versus thyroid-lineage specification |
| Q39178341 | Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish |
| Q38645019 | Proceedings: Regenerative Medicine for Lung Diseases: A CIRM Workshop Report. |
| Q102385882 | Progenitor identification and SARS-CoV-2 infection in human distal lung organoids |
| Q38688592 | Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells. |
| Q49998953 | Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells |
| Q47234893 | Real-time Measurement of Epithelial Barrier Permeability in Human Intestinal Organoids |
| Q64996285 | Recent advances in organoid culture for insulin production and diabetes therapy: methods and challenges. |
| Q47755595 | Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia |
| Q26750856 | Regeneration of the lung: Lung stem cells and the development of lung mimicking devices |
| Q99549255 | Regulation of JAM2 Expression in the Lungs of Streptozotocin-Induced Diabetic Mice and Human Pluripotent Stem Cell-Derived Alveolar Organoids |
| Q102075512 | Rethinking organoid technology through bioengineering |
| Q90149608 | Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy |
| Q45800178 | Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens |
| Q33594853 | SMARCE1 is required for the invasive progression of in situ cancers |
| Q60303922 | Screening-Based Chemical Approaches to Unravel Stem Cell Biology |
| Q55235102 | Single-cell qPCR facilitates the optimization of hematopoietic differentiation in hPSCs/OP9 coculture system. |
| Q52357279 | Stem Cell-Derived Models of Viral Infections in the Gastrointestinal Tract. |
| Q26741792 | Stem Cells Applications in Regenerative Medicine and Disease Therapeutics |
| Q38669057 | Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects |
| Q90229721 | Stem cell-based Lung-on-Chips: The best of both worlds? |
| Q39229334 | Stem cell-derived organoids and their application for medical research and patient treatment |
| Q38857177 | Synthetic Morphogenesis |
| Q99580324 | Synthetic alternatives to Matrigel |
| Q47421495 | Synthetic hydrogels for human intestinal organoid generation and colonic wound repair |
| Q41642440 | Synthetic scaffolds help airway cells reach maturity. |
| Q89474518 | The in vivo genetic program of murine primordial lung epithelial progenitors |
| Q35623383 | The renaissance of developmental biology |
| Q38822489 | Three-dimensional pancreas organogenesis models. |
| Q92410347 | Through the Looking Glass: In Vitro Models for Inhalation Toxicology and Interindividual Variability in the Airway |
| Q55316142 | Tissue engineering toward organ-specific regeneration and disease modeling. |
| Q35754364 | Transcriptome-wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation In Vitro and In Vivo |
| Q99631269 | Translating Embryogenesis to Generate Organoids: Novel Approaches to Personalized Medicine |
| Q50260523 | Translational potential of human brain organoids |
| Q58091057 | Tubular organotypic culture model of human kidney |
| Q47669248 | Using 3D Organoid Cultures to Model Intestinal Physiology and Colorectal Cancer. |
| Q64087583 | Using Lung Organoids to Investigate Epithelial Barrier Complexity and IL-17 Signaling During Respiratory Infection |
| Q26747090 | hPSC-derived lung and intestinal organoids as models of human fetal tissue |
| Q26765886 | iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System |
| Q90172846 | miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma |